Silencing PKC-ε or PKC-ζ in invasive breast cancer cells inhibited TGF-β1 release, suggesting that the trafficking of TGF-β1 from the TGN compartment to the cell membrane is mediated by PKC proteins. Here, PRRT2 is linked to breast carcinoma.